Enzyme alterable alkylating agents. XI. Clinical trials of an esterase-susceptible water-soluble agent (S-73) for regional chemotherapy.
D000230:Adenocarcinoma / Q000188:drug therapy*; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D004950:Esterases; D005260:Female; D006801:Humans; D007269:Injections, Intra-Arterial; D008113:Liver Neoplasms / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D009588:Nitrogen Mustard Compounds / Q000008:administration & dosage* / Q000009:adverse effects; D012509:Sarcoma / Q000188:drug therapy*; D012514:Sarcoma, Kaposi / Q000188:drug therapy; D012995:Solubility; D014062:Tongue Neoplasms / Q000188:drug therapy; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy
D009588:Nitrogen Mustard Compounds; D004950:Esterases